More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Strategic Agreement Signed with RMIT

May 2, 2017 at 12:33 AM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · May 2, 2017 at 12:33 AM EDT

On 6ix: 6ix.com/news/strategic-agreement-signed-with-rmit

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

  • New EU Sales Agreements Signed For MGC DermaMay 1, 2017
  • New Panax Acquisition Agreement Signed, Settlement ImminentDec 15, 2016
  • Strategic Agreement signed with Epilepsy Action AustraliaSep 1, 2016

Earlier from Argent Biopharma

  • New EU Sales Agreements Signed For MGC DermaMay 1, 2017
  • Successful MXC First Cannabinoid ProductionApr 10, 2017
  • European API Extraction Facility CompletedApr 5, 2017
  • Placement of $10m Closed Significantly OversubscribedMar 16, 2017
  • Australian Legislation Changes Fast Track MXCFeb 22, 2017

Later from Argent Biopharma

  • CEO AppointmentMay 10, 2017
  • Positive MGC Derma Clinical Test ResultsMay 22, 2017
  • EU Medical Cannabis License Granted with Strategic AgreementJun 5, 2017
  • First European Distribution Deal Signed for API ProductsJun 19, 2017
  • Botanical Division Update - Europe and AustraliaJul 3, 2017
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer